至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The therapeutic antibody LM609 selectively inhibits ligand binding to human αVβ3 integrin via steric hindrance

Structure, . 2017; 
Andrew J. Borst, Zachary M. James, William N. Zagotta, ..., Frank DiMaio, Marija Backovic, David Veesler
Products/Services Used Details Operation
Gene Synthesis aV Gene (Residues 31-987) Genscript NCBI Accession Code: NM_002210 b3 Gene (Residues 27-718) Genscript NCBI Accession Code: NM_000212 pT350 Vector (Krey et al., 2010) N/A GST-FN9-11 pGEX6P1 Mark H. Ginsberg, MD N/A LM609 Fab This Paper N/A Get A Quote

摘要

关键词

d Crystal structure of the LM609 antigen-binding fragment d LM609 binds to the headpiece region in all aVb3 integrin conformations d The LM609 epitope does not overlap with the RGD ligandbinding pocket d LM609 sterically hinders access of large ligands to the aVb3 RGD-binding site